跳至主要内容
临床试验/EUCTR2013-001312-30-IT
EUCTR2013-001312-30-IT
进行中(未招募)
不适用

ong term effects of selective beta1-adrenoceptor blockade with bisoprolol on hospital readmissions of elderly patients with coexisting heart failure and chronic obstructive pulmonary disease: a multicentre randomized controlled trial

niversità di Napoli Federico II0 个研究点2013年7月18日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
niversità di Napoli Federico II
状态
进行中(未招募)
最后更新
12年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2013年7月18日
结束日期
待定
最后更新
12年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
niversità di Napoli Federico II

入排标准

入选标准

  • 1\. Age \> 75 years
  • 2\. Diagnosis of HF according to AHA/ACC (J Am Coll
  • Cardiol 2006;47:1503\-1505\) made at least 3 months
  • previously. At enrollment, patients must be on stage B\-C or
  • NYHA II\-III.
  • 3\. Diagnosis of COPD according to the ATS/ERS criteria
  • (Eur Respir J. 2004 ;23:932\-46\), made at least 3 months
  • previously, in GOLD stage II\-III.
  • All the enrolled patients must be clinically stable during
  • the preceding 3 weeks and in standard therapeutic regimen,

排除标准

  • 2\. Inability to perform spirometry.
  • 3\. Any type of neoplasm.
  • 4\. Any non\-neoplastic disease limiting life expectance to
  • less than one year.
  • 5\. Cognitive or sensorial impairment preventing all the
  • study planned evaluations
  • 6\. Critical social and enviromental status preventing an
  • adequate drug compliance.
  • 7\. Contraindications to ß\-blocker therapy
  • 8\. Previous evidence of adverse drug reactions to

结局指标

主要结局

未指定

相似试验

已完成
不适用
Impact of Chronic Treatment by β1-adrenergic Antagonists on Nociceptive-Level (NOL) Index Variation After a Standardized Noxious Stimulus Under General AnesthesiaNociception During Anesthesia in Patients Taking β1-adrenergic Antagonist Chronic Treatment
NCT04060095Ciusss de L'Est de l'Île de Montréal33
尚未招募
不适用
The effects of selective alpha-1-adrenergic receptor antagonists in patients with lower urinary tract symptoms caused by benign prostatic hyperplasiawho failed to obtain sufficient efficacy by previous alpha-1-blockades. . A comparison of Naftopidil or Silodosin.Benign Prostatic Hyperplasia
JPRN-UMIN000003609Kansai Medical University Takii Hospital100
已完成
不适用
The effect of Beta-Adrenergic receptor blockade on sympathetic activity and Coagulation in patients with Heart failure (BACH-F study).1. Heart failure<br />2. Hemostasis<br />3. Sympathetic activity.
NL-OMON21698P.W. Kamphuisen, internist, Vasculair Geneeskundige.80
进行中(未招募)
不适用
The effect of beta-adrenergic receptor blockade on sympathetic activity and coagulation in patients with heart failure (BACH-F study) - BACH-F studyCongestive heart failureMedDRA version: 9.1Level: LLTClassification code 10010684Term: Congestive heart failure
EUCTR2007-001994-27-NLetherlands Heart Foundation80
尚未招募
不适用
The effect of beta-adrenergic receptor blockade on sympathetic activity and coagulation in patients with heart failure (BACH-F study)Congestive heart failuresystolic heart failure10019280
NL-OMON31270Academisch Medisch Centrum80